View in EDS

Phase II study of high-sensitivity genotyping of KRAS , NRAS , BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial.

Saved in:
Bibliographic Details
Title: Phase II study of high-sensitivity genotyping of KRAS , NRAS , BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial.
Authors: Santos, C1 (AUTHOR), Azuara, D2 (AUTHOR), Viéitez, J M3 (AUTHOR), Páez, D4 (AUTHOR), Falcó, E5 (AUTHOR), Élez, E6 (AUTHOR), López-López, C7 (AUTHOR), Valladares, M8 (AUTHOR), Robles-Díaz, L9 (AUTHOR), García-Alfonso, P10 (AUTHOR), Bugés, C11 (AUTHOR), Durán, G12 (AUTHOR), Salud, A13 (AUTHOR), Navarro, V14 (AUTHOR), Capellá, G2 (AUTHOR), Aranda, E15 (AUTHOR), Salazar, R1 (AUTHOR) ramonsalazar@iconcologia.net
Source: Annals of Oncology. May2019, Vol. 30 Issue 5, p796-803. 8p. 4 Charts, 1 Graph.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 136864304
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase II study of high-sensitivity genotyping of KRAS , NRAS , BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Santos%2C+C%22">Santos, C</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Azuara%2C+D%22">Azuara, D</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Viéitez%2C+J+M%22">Viéitez, J M</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Páez%2C+D%22">Páez, D</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Falcó%2C+E%22">Falcó, E</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Élez%2C+E%22">Élez, E</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22López-López%2C+C%22">López-López, C</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Valladares%2C+M%22">Valladares, M</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Robles-Díaz%2C+L%22">Robles-Díaz, L</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22García-Alfonso%2C+P%22">García-Alfonso, P</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bugés%2C+C%22">Bugés, C</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Durán%2C+G%22">Durán, G</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Salud%2C+A%22">Salud, A</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Navarro%2C+V%22">Navarro, V</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Capellá%2C+G%22">Capellá, G</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aranda%2C+E%22">Aranda, E</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Salazar%2C+R%22">Salazar, R</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> ramonsalazar@iconcologia.net</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. May2019, Vol. 30 Issue 5, p796-803. 8p. 4 Charts, 1 Graph.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=136864304
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/annonc/mdz082
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 796
    Titles:
      – TitleFull: Phase II study of high-sensitivity genotyping of KRAS , NRAS , BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Santos, C
      – PersonEntity:
          Name:
            NameFull: Azuara, D
      – PersonEntity:
          Name:
            NameFull: Viéitez, J M
      – PersonEntity:
          Name:
            NameFull: Páez, D
      – PersonEntity:
          Name:
            NameFull: Falcó, E
      – PersonEntity:
          Name:
            NameFull: Élez, E
      – PersonEntity:
          Name:
            NameFull: López-López, C
      – PersonEntity:
          Name:
            NameFull: Valladares, M
      – PersonEntity:
          Name:
            NameFull: Robles-Díaz, L
      – PersonEntity:
          Name:
            NameFull: García-Alfonso, P
      – PersonEntity:
          Name:
            NameFull: Bugés, C
      – PersonEntity:
          Name:
            NameFull: Durán, G
      – PersonEntity:
          Name:
            NameFull: Salud, A
      – PersonEntity:
          Name:
            NameFull: Navarro, V
      – PersonEntity:
          Name:
            NameFull: Capellá, G
      – PersonEntity:
          Name:
            NameFull: Aranda, E
      – PersonEntity:
          Name:
            NameFull: Salazar, R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: May2019
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 30
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1